Editas Medicine's chart data is dated 2026-10-08. Recorded technical signals: Golden cross. There are 2 published signal records.
Editas Medicine last closed at $2.84 (+3.27%) on 2026-10-08. Signals today: Golden cross. Listed on Nasdaq. Trailing 12 months PER is -4.6×. Its overall grade ranks 303 of 738 stocks in Healthcare.
About this company
Editas Medicine last closed at $2.84 (+3.27%) on 2026-10-08. Signals today: Golden cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B · 303/738
Valuation grade B-
Related stocks
- CRISPR TherapeuticsCompetitor
CRISPR 기반 유전자편집 치료제 개발 경쟁사
- Intellia TherapeuticsCompetitor
CRISPR 유전자편집 플랫폼 경쟁사
- Vertex PharmaceuticalsCustomer
유전자편집 치료제 공동개발·상업화 파트너
About Editas Medicine
- What technical signals does Editas Medicine (EDIT) have?
- Editas Medicine current technical signals: golden cross (5_20, 0d ago).
- Is Editas Medicine a cup-and-handle pattern?
- No. Editas Medicine has no valid Cup signal right now.
- What published figures are available for Editas Medicine?
- Market cap: $277.24M. Trailing 12 months PER: -4.6×. Latest quarter PBR: 3.22×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Editas Medicine, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.